首页 产品中心
  • BD1047 dihydrobromide

    • BD-1047,BD 1047
    货号: abs810810
    CAS号: 138356-21-5
    分子式: C13H20Cl2N2·2HBr
    分子量: 437.04
    产品说明书
    分享:
    货号-规格 货期 价格 数量
    abs810810-5mg 现货 ¥799.00
    - +
    abs810810-10mg 现货 ¥1078.00
    - +
    abs810810-50mg 现货 ¥3612.00
    - +
    abs810810-100mg 1-2周 ¥5889.00
    - +
    大包装询价
    产品描述
    描述
    BD 1047 dihydrobromide is a selective antagonist of σ receptors.
    纯度
    >98%
    储存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    别名
    BD-1047,BD 1047
    外观
    Powder
    可溶性/溶解性
    H2O : 25 mg/mL (57.20 mM; Need ultrasonic)
    DMSO : 25 mg/mL (57.20 mM; Need ultrasonic)
    生物活性
    靶点
    sigma-1 receptor
    In vitro(体外研究)
    BD1047 (dihydrobromide) prevents that Cutamesine reduces the cell death rate induced by light exposure in murine photoreceptor-derived 661w cells.
    BD1047 (dihydrobromide) attenuates that Cutamesine reduces the mitochondrial damage and the elevated level of caspase 3/7 activity.
    In vivo(体内研究)
    BD1047 (dihydrobromide) (1-10 mg/kg; i.p.) decreases the Apomorphine (APO)-induced climbing behavior at the dose of 10 mg/kg in mice.
    BD1047 (dihydrobromide) counteracts the antidepressant-like effect induced by co-administration of pramipexole and sertraline (but not pramipexole and fluoxetine).
    BD1047 (dihydrobromide) reduces the increasing expression of pNR1, and reverses the Sig-1 R agonists potentiated NMDA-induced pain behaviour and pNR1 immunoreactivity.
    温馨提示:本产品仅作科研实验使用,不支持临床等研究
    • 实验方法 实验条件
      0张,还能上传 8 提交
          提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要咨询”按钮填写您的疑问。
          提交不成功?请联系info@absin.cn。
          我要咨询

      促销资讯 更多

        订购信息
        您可以从我们的授权经销商处购买absin产品或获得技术支持。若要查看您所在地区的经销商,请从以下的下拉列表中选择。
        GO
        • 0